WST

Healthcare · Life Sciences Tools & Services

364.98

-0.01% · 2026-10-02

Buy on trigger

Trade priority: #3 · 80.1

Data coverage: 100%

Setup: pre breakout · 2026-10-02

News: neutral

Next catalyst: Earnings in 12 sessions

Trade plan

PRE_BREAKOUT_SWING_V1_1 · valid until close of 2026-10-05, a material event, or strategy invalidation · shared by every portfolio profile

Action: BUY ON TRIGGERvalid until close of 2026-10-05, a material event, or strategy invalidation
Trigger: 367.39break above resistance · 0.7% / 0.30 ATR away
Entry zone: 367.39–371.47reference 367.39
Initial stop: 358.832.3% · risk 8.56/sh
Target 1: 391.44+6.5% · R:R 2.81 (strong)
Target 2: 407.74+11.0% · R:R 4.71
Risk per share: 8.56strategy-owned; the portfolio panel sizes it per profile
Invalidation: 358.83a close below 1 ATR under the level invalidates the setup before entry

Level 366.98 (PRE_BREAKOUT_V1 selected resistance); ATR14 8.15 on 2026-10-02. Stop: 1 ATR below the breakout level 366.98. Targets: ATR projections 3 / 5 ATR above the level. R:R quality strong to T1 (hard minimum 2.0; 3R would be 393.07, T2 supports 4.71R). Targets are structural and are never moved to reach an R multiple.

Record the fill after you enter: add position. The strategy then manages the stop, targets and the next action.

Your portfolio · San

profile-specific: quantity, risk budget, exposure, cash impact

Profile: Sanequity 2,000.00 USD · whole shares
Current holding: noneno open position in this profile
Recommended quantity: 1 sh367.39 · 18.4% of portfolio · bound by max position value
Risk budget: 10.000.5% of 2,000.00 · planned risk 8.56
Portfolio risk: 0.00 openremaining 40.00 → 31.44 after
Exposure: 0 / 3 positionsHealthcare: 0 / 2 · 0.00 of 1,000.00 cap
Cash impact: 2,000.00 → 1,632.61derived from the ledger
Eligibility: BUY ON TRIGGERsame as the strategy view

Entry, stop, targets and R:R are strategy-owned and identical for every profile; only this portfolio's quantity, risk, exposure and cash differ. Manage profiles · record a fill

Quality gates

hard entry gates of the strategy · PASS / FAIL / UNKNOWN

Gate	Verdict	Detail
Data freshness	PASS	0 completed session(s) behind the calendar
Price	PASS	close 364.98 at or above the 10 floor
Market cap	PASS	market cap 23.90B (finnhub, 2026-10-02)
Liquidity	PASS	ADV20 231.5M (STRONG_LIQUIDITY)
Sector	PASS	sector Healthcare (finnhub_industry)
Regime	PASS	regime RISK_ON
Earnings	PASS	earnings in 12 sessions (2026-10-21)
News / event risk	PASS	news context NEUTRAL
Chase protection	PASS	0.20 ATR above EMA20, session move -0.00 ATR
R:R	PASS	reward/risk 2.81 to target 1 (strong), 4.71 to target 2
Portfolio capacity	PASS	1 shares (367), bound by max position value
Data quality	PASS	current session data, valid technical snapshot, trigger and ATR; critical facts known

Why this action

Technical

0.7% below the trigger 367.39 (resistance 366.98)
RS20 positive vs SPY and QQQ (+6.9% / +2.0%)
EMA20 extension 0.20 ATR
RSI14 54.2 inside the 50-70 band
stop 358.83: 1 ATR below the breakout level 366.98
RS20 vs SPY 6.9%, vs QQQ 2.0%

Options

volume 1.22× the 20D baseline (neither) · selected contracts only, delayed

News and events

news context neutral (6 canonical items in window)
earnings 2026-10-21 (12 sessions, finnhub); event risk low
insider · low · unknown: WEST PHARMACEUTICAL SERVICES INC: 4 filed
other · low · unknown: Drug Development Inputs & Services Stocks Q2 Highlights: West Pharmaceutical Services (NYS

Market and risk

regime RISK ON: SPY: trend UP, volatility NORMAL; QQQ: trend UP, volatility NORMAL

Chart

252 sessions · EMA20 / SMA50 / SMA150 / SMA200 default · strategy levels drawn when a plan exists

2026-10-02O 364.74H 368.85L 363.26C 364.98 -0.01%Vol 473,017RVOL20 0.75SMA50 351.83SMA150 317.49SMA200 302.32EMA20 363.36RSI14 54.2MACD 5.904 / 6.018 / -0.114ATR14 8.15RS20 SPY 6.9% · QQQ 2.0%

Indicator history is derived from the stored bars with the accepted M3 functions (WORKSTATION_SERIES_V1); the scanner’s persisted values remain authoritative. Reconciliation at the scan session: 8 match.

Trade priority

operational attention ranking, not a forecast

Rank #3 · priority 80.1 / 100 · coverage 100%

technical readiness28/30
structure quality6/10
relative strength14/15
participation7/10
risk reward11/15
news context8/10
event risk5/5
urgency1/5

operational attention priority not a return forecast. Missing inputs lower coverage, never the score.

Setup evidence · PRE_BREAKOUT_V1

Setup state: PRE_BREAKOUT
Resistance: 366.98
Distance: 0.54%
Close: 364.98
SMA50: 351.83
SMA150 / SMA200: 317.49 / 302.32
RSI14: 54.2
EMA20 extension: 0.2 ATR
RS20 vs SPY: +6.9%
RS20 vs QQQ: +2.0%

Hard requirements · 8/8 passed

PASS
Confirmed resistance
resistance=366.98 exists eligible=true
PASS
Distance to resistance
distance_pct=0.545 · resistance=366.98 · close=364.98 inclusive_between min=0 · max=3
PASS
Close above SMA50
close=364.98 · sma50=351.8306 > right_operand=sma50
PASS
SMA150 ≥ SMA200
sma150=317.4944 · sma200=302.32 >= right_operand=sma200
PASS
RSI14 band
rsi14=54.1964 inclusive_between min=50 · max=70
PASS
EMA20 extension (ATR)
extension_atr=0.1983 · close=364.98 · ema20=363.3636 · atr14=8.1527 <= max=1.5
PASS
RS20 vs SPY or QQQ
SPY=0.0695 · QQQ=0.0205 OR > SPY=0 · QQQ=0
PASS
Resistance quality
distinct_touches=2 policy_and_minimum_touches min=2

Supporting evidence · 5/6 passed

PASS
ATR compression
current_atr_pct=0.0223 · median_previous_60_atr_pct=0.0233 · ratio=0.9595 < right_operand=median_previous_60_atr_pct
FAIL
Volume contraction
recent_volume=548,472.4052 · baseline_volume=610,122.5699 · ratio=0.899 < max=0.85
PASS
Higher lows
low_1=331.99 · low_2=359.52 · low_3=366.55 low_3 > low_2 > low_1 required_pivots=3
PASS
Full MA alignment
sma50=351.8306 · sma150=317.4944 · sma200=302.32 sma50 > sma150 > sma200
PASS
RS20 vs SPY positive
SPY=0.0695 > min=0
PASS
RS20 vs QQQ positive
QQQ=0.0205 > min=0

PRE_BREAKOUT_V1 · scan run 417 · session 2026-10-02 · evaluated as of 2026-10-04T13:23:16.862423Z. Supporting evidence never changes the trigger; UNKNOWN is never collapsed into false.

Intelligence timeline

6 canonical of 6 items in window · duplicates collapsed

2026-10-0217:10 UTC
WEST PHARMACEUTICAL SERVICES INC: 4 filed
SEC EDGARTier 1 · primaryinsiderlow materialityunknownfact
2026-10-0119:57 UTC
Drug Development Inputs & Services Stocks Q2 Highlights: West Pharmaceutical Services (NYSE:WST)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at West Pharmaceutical Services (NYSE:WST) and the best and worst performers in the drug development inputs & services industry.
YahooTier 3 · providerotherlow materialityunknownreported fact
2026-09-1520:37 UTC
WEST PHARMACEUTICAL SERVICES INC: 4 filed
SEC EDGARTier 1 · primaryinsiderlow materialityunknownfact
2026-09-1019:33 UTC
WEST PHARMACEUTICAL SERVICES INC: 3 filed
SEC EDGARTier 1 · primaryinsiderlow materialityneutralfact+2 duplicate reports
hidden
4 provider-tagged items never name the company and are kept as context only.

canonical items of the last 10 sessions; analyst/industry/macro commentary and social sources excluded from the direction tally; gating uses tier 1-3 HIGH items within 3 (negative) / 2 (unknown direction) sessions

Catalysts and filings

Event	Date	In	Materiality	Source
Earnings (before the open)	2026-10-21	12 sessions	high	finnhub · Tier 3 · provider

Options activity

AVAILABLE_DELAYED · session 2026-10-02 · selected contracts, delayed

Session volume: 62
5D baseline: 47
20D baseline: 51
Volume / 20D: 1.22x
Call / put volume: 57 / 5
Call / put ratio: 11.4
Top-3 contract share: 100%
Top expiration: 2026-10-16 100%

Activity trend · last 26 sessions

Session	Volume	5D	20D	/ 20D
2026-09-28	113	62	43	2.65x
2026-09-29	10	83	47	0.21x
2026-09-30	72	80	47	1.55x
2026-10-01	35	93	49	0.71x
2026-10-02	62	47	51	1.22x

Call vs put volume

calls 92%puts 8%

Expiration concentration

2026-10-1662 · 100%

Contract concentration

O:WST261016C0038000055 · 89%
O:WST261016P003600005 · 8%
O:WST261016C003700002 · 3%

Top contracts · session 2026-10-02

Contract	Type	Strike	Expiration	DTE	Volume	5D avg	20D avg	/ 20D	Return	Moneyness
O:WST261016C00380000	CALL	380	2026-10-16	14	55	2	insufficient history	insufficient history	-10.8%	OTM (-4.0%)
O:WST261016P00360000	PUT	360	2026-10-16	14	5	2	insufficient history	insufficient history	0.0%	OTM (1.4%)
O:WST261016C00370000	CALL	370	2026-10-16	14	2	2	insufficient history	insufficient history	0.0%	OTM (-1.4%)

OPTIONS_SELECTION_M9_V1 selected contracts only · provider capability DELAYED · delayed · Top 15 selected contracts by session volume; 5D/20D averages use strictly prior sessions (M10), INSUFFICIENT_HISTORY is shown, never zero.

M13 observations for this session

Technical setup present (PRE_BREAKOUT_V1): TRUE
Technical and options context share a session: TRUE
Activity above its own 20-session baseline: FALSE
Activity below its own 20-session baseline: FALSE
Recent 5-session baseline above 20-session baseline: FALSE
Recent 5-session baseline below 20-session baseline: FALSE
Volume concentrated in top 3 contracts: TRUE
Volume concentrated in one expiration: TRUE
Calls carry most session volume: TRUE
Puts carry most session volume: FALSE
Call and put volume roughly balanced: FALSE
Enrichment data (snapshot/OI/IV/Greeks) available: FALSE
Enrichment data unavailable: TRUE
Real flow data unavailable: TRUE
Flow events present in replay window: NOT_EVALUABLE

Flow

Flow events—

Clusters—

Sweep candidates—

Block candidates—

Aggressor candidates—

Premium coverage—

Flow engine is ready. Trades and Quotes are not available with the current provider capabilities; this area populates automatically from the same M11 engine when real persisted facts exist. Synthetic fixture flow is never shown.

Evidence alerts

3 · ALERT_POLICY_V1

Category	Alert	Previous	Current	Sessions	Workflow
Changed	Options activity vs 20D baseline rose	0.71	1.22	2026-10-01 → 2026-10-02	New
Changed	Top-3 contract concentration increased	0.57	1	2026-10-01 → 2026-10-02	New
Changed	Call / put volume mix changed	0.54	0.92	2026-10-01 → 2026-10-02	New

Decision trace

PRE_BREAKOUT_SWING_V1_1 · generated 2026-10-04 16:59 UTC · strategy 073b221a9cd0…

setup_eligiblePASSPRE_BREAKOUT_V1 on 2026-10-02: all 8 hard conditions passresistance=366.98 · close=364.98 · distance_pct=0.5449888277290316
trigger_statePASSNOT_TRIGGERED; trigger 367.39 is 0.30 ATR above the close (within 1 ATR)trigger_price=367.39 · distance_to_trigger_atr=0.3 | threshold near_trigger_atr=1
data_freshnessPASS0 completed session(s) behind the calendarsessions_behind=0 | threshold max_sessions_behind=1
price_gatePASSclose 364.98 at or above the 10 floorclose=364.98 | threshold min_price=10
market_cap_gatePASSmarket cap 23.90B (finnhub, 2026-10-02)market_cap_usd=23898910000 | threshold min_market_cap_usd=1000000000
liquidity_gatePASSADV20 231.5M (STRONG_LIQUIDITY)adv_dollar=231461217.07 · strong_liquidity=true | threshold min_adv_dollar=25000000, strong_adv_dollar=50000000
sector_gatePASSsector Healthcare (finnhub_industry)
market_regime_gatePASSregime RISK_ONregime=RISK_ON · risk_multiplier=1
event_risk_gatePASSearnings in 12 sessions (2026-10-21)earnings_sessions_away=12 | threshold earnings_block_sessions=5
news_gatePASSnews context NEUTRAL
chase_gatePASS0.20 ATR above EMA20, session move -0.00 ATRextension_atr=0.2 | threshold breakout_max_extension_atr=2
risk_rewardPASSreward/risk 2.81 to target 1 (strong), 4.71 to target 2reward_risk_1=2.81 · reward_risk_2=4.71 | threshold min_reward_risk_1=2
portfolio_gatePASS1 shares (367), bound by max position valueshares=1 · risk_amount=8.56 · regime_multiplier=1 · share_increment=1
data_qualityPASScurrent session data, valid technical snapshot, trigger and ATR; critical facts known
finalPASSBUY_ON_TRIGGER

Snapshot history: 2026-10-02 BUY_ON_TRIGGER · 2026-10-01 BUY_ON_TRIGGER

Actions are generated from the configured trading strategy and current available market/intelligence data. They are not guarantees of future performance.